Neuroprotective Effects of Magnesium Sulphate in Anesthesia and Neurocritical Care Settings: A Systematic Review

<ns3:p>Background Magnesium sulphate (MgSO₄) is increasingly recognized for its anti-inflammatory and neuroprotective properties, making it a promising adjunct in neuroanesthesia and neurocritical care. Its pharmacological actions—such as NMDA receptor antagonism, calcium channel blockade, and modulation of inflammatory pathways—may contribute to improved patient outcomes. This systematic review evaluates current evidence on the role of MgSO₄ in neuroanesthesia and neurocritical care settings. Methods A systematic search was conducted in PubMed, Scopus, Cochrane Library, ProQuest, and ScienceDirect, from inception until April 18, 2025 for studies evaluating the effects of MgSO₄ in adult patients undergoing neurosurgical procedures or treated in neurocritical care. Outcomes of interest included neurological recovery, cerebral vasospasm, delayed cerebral ischemia (DCI), postoperative opioid requirements, hemodynamic stability, and adverse events. Risk of bias was assessed using the Cochrane Risk of Bias 2.0 tool and the Newcastle-Ottawa Scale. Results Ten studies were included in this review. MgSO₄ administration was consistently associated with improved neurological recovery, as indicated by better modified Rankin Scale scores. Several trials reported a significant reduction in the incidence of cerebral vasospasm and DCI among MgSO₄-treated patients. Magnesium also demonstrated analgesic benefits, with reduced postoperative opioid requirements and pain scores. Hemodynamic stability was enhanced in the magnesium groups across multiple studies. Importantly, no significant increase in adverse events was reported, supporting the safety of MgSO₄ in this context. Conclusion This systematic review supports the potential of MgSO₄ as a safe and effective adjunct in neuroanesthesia and neurocritical care. Its anti-inflammatory and neuroprotective effects appear to translate into meaningful clinical benefits.</ns3:p>

Authors

Institutions

Publication Details

Journal
F1000Research
Published
2025-11-26
DOI
https://doi.org/10.12688/f1000research.171465.1
Primary Topic
Magnesium Oxide Properties and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuroprotective Effects of Magnesium Sulphate in Anesthesia and Neurocritical Care Settings: A Systematic Review

Monika Widiastuti, Elvan Wiyarta, Dewi Yulianti Bisri, Iwan Fuadi et al.
F1000Research
Magnesium Oxide Properties and Applications
article

Neuroprotective Effects of Magnesium Sulphate in Anesthesia and Neurocritical Care Settings: A Systematic Review

Monika Widiastuti, Elvan Wiyarta, Dewi Yulianti Bisri, Iwan Fuadi, Suwarman Suwarman, Decky Aditya Zulkarnaen, Khairunnisai Tarimah
article en

Abstract

<ns3:p>Background Magnesium sulphate (MgSO₄) is increasingly recognized for its anti-inflammatory and neuroprotective properties, making it a promising adjunct in neuroanesthesia and neurocritical care. Its pharmacological actions—such as NMDA receptor antagonism, calcium channel blockade, and modulation of inflammatory pathways—may contribute to improved patient outcomes. This systematic review evaluates current evidence on the role of MgSO₄ in neuroanesthesia and neurocritical care settings. Methods A systematic search was conducted in PubMed, Scopus, Cochrane Library, ProQuest, and ScienceDirect, from inception until April 18, 2025 for studies evaluating the effects of MgSO₄ in adult patients undergoing neurosurgical procedures or treated in neurocritical care. Outcomes of interest included neurological recovery, cerebral vasospasm, delayed cerebral ischemia (DCI), postoperative opioid requirements, hemodynamic stability, and adverse events. Risk of bias was assessed using the Cochrane Risk of Bias 2.0 tool and the Newcastle-Ottawa Scale. Results Ten studies were included in this review. MgSO₄ administration was consistently associated with improved neurological recovery, as indicated by better modified Rankin Scale scores. Several trials reported a significant reduction in the incidence of cerebral vasospasm and DCI among MgSO₄-treated patients. Magnesium also demonstrated analgesic benefits, with reduced postoperative opioid requirements and pain scores. Hemodynamic stability was enhanced in the magnesium groups across multiple studies. Importantly, no significant increase in adverse events was reported, supporting the safety of MgSO₄ in this context. Conclusion This systematic review supports the potential of MgSO₄ as a safe and effective adjunct in neuroanesthesia and neurocritical care. Its anti-inflammatory and neuroprotective effects appear to translate into meaningful clinical benefits.</ns3:p>

F1000ResearchVol. 14
Pelita Harapan University (ID), University of Mataram (ID), University of Brawijaya (ID), University of Indonesia (ID), Universitas Islam Al-Azhar Mataram (ID), Universitas 45 Mataram (ID), Padjadjaran University (ID)
Openalex Percentile: Top 70%
Magnesium Oxide Properties and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.